Publication | Closed Access

174P A real-world study of PD-1 inhibitors combined with TKIs for HCC with major vascular invasion as the conversion therapy: A prospective, non-randomized, open-label cohort study

Translational MedicineVascular DiseaseConversion TherapyNovel TherapyCardiovascular DiseasePharmacologyPd-1 InhibitorsPharmacotherapyMedicineMajor Vascular Invasion